Projects funded by the NCN
PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGICAL INTERVENTION
2012/07/E/NZ7/01269
Keywords:
osteoarthritis (OA) cannabinoid CB1 receptor vanilloid TRPV1 receptor anandamide (AEA)
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
dr hab. Katarzyna Starowicz-Bubak
Number of co-investigators in the project: 7
Call: SONATA BIS 2 - announced on 2012-09-15
Amount awarded: 1 498 477 PLN
Project start date (Y-m-d): 2013-08-08
Project end date (Y-m-d): 2017-06-07
Project duration:: 46 months (the same as in the proposal)
Project status: Project settled